English
Home > Products > Orlistat

China Orlistat Factory

So as to give you ease and enlarge our company, we also have inspectors in QC Team and assure you our greatest support and product or service for Orlistat,CAS NO 96829-58-2,96829-58-2,Orlistat API, The principle of our company is to provide high-quality products, professional service, and honest communication. Welcome all friends to place trial order for creating a long-term business relationship.
Orlistat, We are going to supply much better items with diversified designs and professional services. We sincerely welcome friends from over the world to visit our company and cooperate with us on the basis of long-term and mutual benefits.

Related Products

Hot Products

  • Cefpiramide sodium

    Cefpiramide sodium

    Product Name:Cefpiramide sodium
    Molecular Formula:C25H25N8NaO7S2
    Molecular Weight;636.63
    CAS Registry Number;74849-93-7
  • 2-Bromo-2'-chloroacetophenone

    2-Bromo-2'-chloroacetophenone

    Product Name:2-Bromo-2'-chloroacetophenone
    Molecular Formula:C8H6BrClO
    Molecular Weight:233.49
    CAS Registry Number:5000-66-8
  • Aripiprazole

    Aripiprazole

    Product Name:Aripiprazole
    Molecular Formula:C23H27Cl2N3O2
    Molecular Weight;448.39
    CAS Registry Number;129722-12-9
  • Allyl chloroformate

    Allyl chloroformate

    Product Name:Allyl chloroformate
    Molecular Formula:C4H5ClO2
    Molecular Weight:120.53
    CAS Registry Number;2937-50-0
  • 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride

    1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride

    Product Name:1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
    Molecular Formula:C8H18ClN3
    Molecular Weight:191.7
    CAS Registry Number:25952-53-8
  • Famotidine

    Famotidine

    Product Name:Famotidine
    Molecular Formula:C8H15N7O2S3
    Molecular Weight:337.45
    CAS Registry Number:76824-35-6
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

Orlistat API

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept